1 not yet recruiting, 1 terminated. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Not yet recruiting 1, Terminated 1 |
| Phase 1 | 1 | Terminated 1 |
Follow acetohydroxamic acid: new trials by email Literature Review of acetohydroxamic acid trials Research Report on acetohydroxamic acid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Acetohydroxamic Acid Combined With a Short-Course Regimen for MDR-TB (AHA-PLUS) Acetohydroxamic Acid, Placebo - Multidrug-Resistant Tuberculosis, Rifampicin-resistant Tuberculosis | Phase 2 | Not yet recruiting | Shanghai Pulmonary Hospital, Shanghai, China | 120 | 2026-02-21 | 2026-02-06 |
| Manipulating the Gut Microbiome Study Acetohydroxamic Acid Oral Tablet, No treatment - Urea Cycle Disorder | Phase 1 / Phase 2 | Terminated | Nicholas Ah Mew | 4 | 2017-03-24 | 2021-12-15 |
Ornithine Carbamoyltransferase Deficiency Disease (1) · Tuberculosis, Multidrug-Resistant (1) · Urea Cycle Disorders, Inborn (1)
Nicholas Ah Mew (1) · Shanghai Pulmonary Hospital, Shanghai, China (1)
China (1) · United States (1)